Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression

被引:1
|
作者
Wanwisa Deenin [1 ]
Wachirawadee Malakul [1 ]
Tantip Boonsong [2 ]
Ittipon Phoungpetchara [3 ]
Sakara Tunsophon [1 ,4 ]
机构
[1] Department of Physiology, Faculty of Medical Science, Naresuan University
[2] Department of Biochemistry, Faculty of Medical Science, Naresuan University
[3] Department of Anatomy, Faculty of Medical Science, Naresuan University
[4] Centre of Excellence for Innovation in Chemistry, Naresuan University
关键词
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Non-alcoholic fatty liver disease(NAFLD) is a global health issue that is correlated with obesity and oxidative stress.AIM To evaluate the anti-NAFLD effect of papaya in high fat diet induced obesity in rats.METHODS Four-week-old male Sprague-Dawley rats were divided into four groups after 1 wk of acclimatization: Group 1 was the rats fed a normal diet(C); group 2 was the rats fed a high fat diet(HFD); group 3 was the rats fed a HFD with 0.5 m L of papaya juice/100 g body weight(HFL), and group 4 was the rats fed a HFD with 1 m L of papaya juice/100 g body weight(HFH) for 12 wk. At the end of the treatment, blood and tissue samples were collected for biochemical analyses and histological assessment.RESULTS The results of the HFH group showed significantly reduced body weight(HFH vs HFD, P < 0.01), decreased NAFLD score(HFH vs HFD, P < 0.05), and reduced hepatic total cholesterol(HFL vs HFD, P < 0.01; HFH vs HFD, P < 0.001), hepatic triglyceride(HFH vs HFD, P < 0.05), malondialdehyde(HFL, HFH vs HFD, P < 0.001), tumour necrosis factor-α(HFH vs HFD, P < 0.05) and interleukin-6(HFH vs HFD, P < 0.05) when compared to the HFD group. However, the liver weight showed no significant difference among the groups. The activities of catalase and superoxide dismutase significantly increased in HFH when compared with the HFD group(P < 0.05 and P < 0.001, respectively). The suppression of transcriptional factors of hepatic lipogenesis, including sterol regulatory elementbinding protein 1 c and fatty acid synthase, were observed in the papaya treated group(HFH vs HFD, P < 0.05). These beneficial effects of papaya against HFDinduced NAFLD are through lowering hepatic lipid accumulation, suppressing the lipogenic pathway, improving the balance of antioxidant status, and lowering systemic inflammation.CONCLUSION These current results provide experimental-based evidence suggesting papaya is an efficacious medicinal fruit for use in the prevention or treatment of NAFLD.
引用
收藏
页码:315 / 327
页数:13
相关论文
共 50 条
  • [31] Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
    Li, Yunjia
    Yang, Menghan
    Lin, Haiyan
    Yan, Weixin
    Deng, Guanghui
    Ye, Haixin
    Shi, Hao
    Wu, Chaofeng
    Ma, Guoliang
    Xu, Shu
    Tan, Qinxiang
    Gao, Zhuowei
    Gao, Lei
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [32] Non-alcoholic fatty liver disease in obese children and adolescents
    Denzer, C.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2013, 56 (04) : 517 - 527
  • [33] Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model
    Lu, Yulei
    Lin, Youzhi
    Huang, Xiaoqing
    Wu, Shengming
    Wei, Jian
    Yang, Chun
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (06) : 2398 - 2408
  • [34] Non-alcoholic Fatty Liver Disease in Non-obese Patients
    Christopher J. Schmoyer
    Mohammad S. Siddiqui
    Current Hepatology Reports, 2017, 16 (4) : 382 - 390
  • [35] Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease
    Das, S. K.
    Balakrishnan, V.
    Mukherjee, S.
    Vasudevan, D. M.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2008, 68 (04): : 323 - 334
  • [36] Protocatechuic Acid Protects Mice Against Non-Alcoholic Fatty Liver Disease by Attenuating Oxidative Stress and Improving Lipid Profile
    Boroujeni, Zeinab Zeinalian
    Khorsandi, Layasadat
    Zeidooni, Leila
    Badiee, Mahdieh Sadat
    Khodayar, Mohammad Javad
    REPORTS OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 13 (02): : 218 - 230
  • [37] Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
    Videla, LA
    Rodrigo, R
    Orellana, M
    Fernandez, V
    Tapia, G
    Quiñones, L
    Varela, N
    Contreras, J
    Lazarte, R
    Csendes, A
    Rojas, J
    Maluenda, F
    Burdiles, P
    Diaz, JC
    Smok, G
    Thielemann, L
    Poniachik, J
    CLINICAL SCIENCE, 2004, 106 (03) : 261 - 268
  • [38] Pathogenetic role of inflammation and insulin resistance in non-alcoholic fatty liver disease in obese children
    Stepanov, Yu. M.
    Zavhorodnia, N. Yu.
    Tatarchuk, O. M.
    Klenina, I. A.
    Konenko, I. S.
    Petishko, O. P.
    ZAPOROZHYE MEDICAL JOURNAL, 2022, 24 (05) : 538 - 546
  • [39] Insulin resistance, inflammation, and non-alcoholic fatty liver disease
    Tilg, Herbert
    Moschen, Alexander R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (10): : 371 - 379
  • [40] Treating inflammation to combat non-alcoholic fatty liver disease
    Wiering, Leke
    Tacke, Frank
    JOURNAL OF ENDOCRINOLOGY, 2023, 256 (01)